FDA warns on mixing opioid addiction treatments, other meds

The Food and Drug Administration has issued new warnings about the dangers of combining medication for opioid addiction with antidepressants and other drugs that also slow breathing and brain activity.

The FDA warns that mixing such drugs can cause difficulty breathing, coma or death and should be done with caution.

Many patients fighting opioid addiction by taking methadone or buprenorphine (byoo-preh-NOR'-feen) also take other that slow action of the central nervous system. Those include the medications Ambien and Lunesta for insomnia, Valium and Xanax for anxiety, muscle relaxers Soma and Zanaflex and Abilify, Invega, Saphris and others.

Meanwhile, the agency stressed that treating opioid addiction with medication is crucial to curbing the U.S. opioid epidemic.

Explore further

Starting opioid addiction treatment in the ED is cost-effective

© 2017 The Associated Press. All rights reserved.

Citation: FDA warns on mixing opioid addiction treatments, other meds (2017, September 20) retrieved 10 May 2021 from https://medicalxpress.com/news/2017-09-fda-opioid-addiction-treatments-meds.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments